Yuta Hoshi, Tomohiro Enokida, Shingo Tamura, Torahiko Nakashima, Susumu Okano, Takao Fujisawa, Masanobu Sato, Akihisa Wada, Hideki Tanaka, Naohiro Takeshita, et al. Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma. Frontiers in Oncology. 2024. 14
Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Mayuko Izumi, Tomoki Kuge, Maiko Naito, Yumiko Mizuno, Yuta Yamaguchi, et al. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer. JCI insight. 2024. 9. 3
Takeshi Fujisawa, Atsushi Motegi, Hidenari Hirata, Sadamoto Zenda, Hidehiro Hojo, Masaki Nakamura, Hidekazu Oyoshi, Kento Tomizawa, Yuzheng Zhou, Keiko Fukushi, et al. Long-term outcomes of patients with oral cavity cancer receiving postoperative radiotherapy after salvage neck dissection for cervical lymph node recurrence. Head & Neck. 2023
Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi, et al. Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Oral Oncology. 2023. 147. 106615-106615
Hideki Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Naohiro Takeshita, Ryutaro Onaga, Yuta Hoshi, Akihisa Wada, Masanobu Sato, et al. Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck. Frontiers in Oncology. 2023. 13
2019/01 - 2021/03 Division of Hematology Oncology, Laboratory of Nina Bhardwaj, Hess Center for Science & Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai, USA Postdoctoral fellow
